BNTX Financials
Biontech Se - Financial statements & key metrics
Stock Price
$100.76
Market Cap
$25.28B
EPS
$-2.81
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.75B
Gross Profit
$2.21B
Operating Income
$-1.31B
Net Income
$-665.30M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$22.53B
Total Liabilities
$3.12B
Shareholders Equity
$19.41B
Cash & Equivalents
$9.76B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$207.70M
CapEx
$452.30M
Free Cash Flow
$-244.60M
Profitability Metrics
Gross Margin
82.5%
Operating Margin
-0.0%
Net Margin
-0.2%
ROE
-0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BNTX revenue?
BNTX's most recent quarterly revenue was $2.75B. Annual revenue can be calculated by summing the four most recent quarters.
Is BNTX profitable?
BNTX reported a loss of $665.30M in the most recent quarter. The net profit margin is -0.2%.
What is BNTX market cap?
BNTX has a market capitalization of $25.28B, making it a large-cap stock.
Does BNTX have debt?
View BNTX's balance sheet for debt information.
What is BNTX cash flow?
BNTX's most recent quarterly free cash flow was $-244.60M.